Skip to main content
TipRanks
Go Ultimate75% OFF

ADARx Pharmaceuticals (ADRX) Ratios

9 Followers

ADARx Pharmaceuticals Ratios

ADRX's free cash flow for Q3 2026 was $-27.07M. For the 2026 fiscal year, ADRX's free cash flow was decreased by $-197.00K and operating cash flow was $-26.88M. See a summary of the company’s cash flow.

Financial ratios
RatiosDec 25
Liquidity Ratios
Current Ratio16.18
Quick Ratio16.18
Cash Ratio2.18
Solvency Ratio-0.10
Operating Cash Flow Ratio8.60
Short-Term Operating Cash Flow Coverage0.00
Net Current Asset Value$ -216.53M
Leverage Ratios
Debt-to-Assets Ratio0.02
Debt-to-Equity Ratio-0.04
Debt-to-Capital Ratio-0.04
Long-Term Debt-to-Capital Ratio0.00
Financial Leverage Ratio-2.51
Debt Service Coverage Ratio0.00
Interest Coverage Ratio0.00
Debt to Market Cap0.00
Interest Debt Per Share0.10
Net Debt to EBITDA0.68
Profitability Margins
Gross Profit Margin100.00%
EBIT Margin-2562.05%
EBITDA Margin-2494.58%
Operating Profit Margin-2562.05%
Pretax Profit Margin-2119.11%
Net Profit Margin-2119.11%
Continuous Operations Profit Margin-2119.11%
Net Income Per EBT100.00%
EBT Per EBIT82.71%
Return on Assets (ROA)-14.40%
Return on Equity (ROE)36.14%
Return on Capital Employed (ROCE)-18.52%
Return on Invested Capital (ROIC)-18.45%
Return on Tangible Assets-14.40%
Earnings Yield-5.01%
Efficiency Ratios
Receivables Turnover0.00
Payables Turnover0.00
Inventory Turnover0.00
Fixed Asset Turnover0.29
Asset Turnover0.01
Working Capital Turnover Ratio0.00
Cash Conversion Cycle0.00
Days of Sales Outstanding0.00
Days of Inventory Outstanding0.00
Days of Payables Outstanding0.00
Operating Cycle0.00
Cash Flow Ratios
Operating Cash Flow Per Share3.48
Free Cash Flow Per Share3.44
Dividend Paid and CapEx Coverage Ratio89.37
Capital Expenditure Coverage Ratio89.37
Operating Cash Flow Coverage Ratio33.88
Operating Cash Flow to Sales Ratio76.05
Free Cash Flow Yield17.79%
Valuation Ratios
Price-to-Earnings (P/E) Ratio-19.95
Price-to-Sales (P/S) Ratio422.72
Price-to-Book (P/B) Ratio-7.21
Price-to-Free Cash Flow (P/FCF) Ratio5.62
Price-to-Operating Cash Flow Ratio5.56
Price-to-Earnings Growth (PEG) Ratio0.00
Enterprise Value Multiple-16.26
Enterprise Value1.40B
EV to EBITDA-16.26
EV to Sales405.68
EV to Free Cash Flow5.39
EV to Operating Cash Flow5.33
Tangible Book Value Per Share-2.68
Shareholders’ Equity Per Share-2.68
Tax and Other Ratios
Effective Tax Rate0.00
Revenue Per Share0.05
Net Income Per Share-0.97
Tax Burden1.00
Interest Burden0.83
Research & Development to Revenue20.73
SG&A to Revenue5.89
Stock-Based Compensation to Revenue1.78
Income Quality-3.59

Currency in USD